That's why the SP fell massively....But the first line therapy was the primary use intended to maximise revenues.
It's not a total failure but it is a big disappointment to the market.
BUT MSB doesn't have such problems! And it has a platform of technology applications for the MPC stem cells.
Still trying to discredit me? Why bother?
What I say on HC can't influence other posters ....or the SP...can it?
MSB Price at posting:
$3.88 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)